Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Lefitolimod |
Trade Name | |
Synonyms | MGN1703|MGN 1703|MGN-1703 |
Drug Descriptions |
Lefitolimod (MGN1703) is a TLR9 agonist, which results in increased anti-tumor immune response, and may lead to decreased tumor growth (PMID: 25577571, PMID: 31741757). |
DrugClasses | TLR9 Agonist 9 |
CAS Registry Number | 1548439-51-5 |
NCIT ID | C94207 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ipilimumab + Lefitolimod | Ipilimumab Lefitolimod | 0 | 1 |
Lefitolimod | Lefitolimod | 0 | 0 |